ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)

China · Delayed Price · Currency is CNY

7.54

-0.14 (-1.82%)

Jul 30, 2026, 3:04 PM CST

-38.65% (1Y)

Market Cap	1.93B -34.7%
Revenue (ttm)	862.85M +2.9%
Net Income	17.80M -48.1%
EPS	0.07 -48.8%
Shares Out	256.06M
PE Ratio	104.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,980,980
Open	7.67
Previous Close	7.68
Day's Range	7.41 - 7.86
52-Week Range	6.93 - 15.20
Beta	0.44
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About SHE:300254

ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infective drugs, anti-allergic drugs, smoking cessation drugs, pediatric drugs, respiratory system drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, nephropathy drugs, anti-depressants, medicines, pharmaceutical raw materials, and intermediates, commerce, etc. The company’s product portfolio includes Fosfomycin tromethamine powder, ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2005

Employees 1,162

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300254

Full Company Profile

Financial Performance

In 2025, SHE:300254's revenue was 870.79 million, an increase of 2.86% compared to the previous year's 846.61 million. Earnings were 24.85 million, a decrease of -41.10%.

Financial Statements